Estimating Relative Fracture Reduction of Romosozumab versus Teriparatide for Postmenopausal Osteoporosis Using Bone Mineral Density Outcomes

被引：0
|
作者：
Johnson, Benjamin [1 ]
McClung, Michael [2 ]
Silverman, Stuart [3 ]
Gandra, Shravanthi [4 ]
Timoshanko, Jennifer [5 ]
Stollenwerk, Bjorn [6 ]
机构：
[1] Amgen Ltd, Cambridge, England
[2] Oregon Osteoporosis Ctr, Portland, OR USA
[3] Cedars Sinai, Los Angeles, CA USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] UCB Pharma Ltd, Slough, Berks, England
[6] Amgen GmbH, Risch Rotkreuz, Switzerland
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-646
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [31] The effect of different doses of calcitonin on bone mineral density and fracture risk in postmenopausal osteoporosis
    Hizmetli, S
    Elden, H
    Kaptanoglu, E
    Nacitarhan, V
    Kocagil, S
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1998, 52 (07) : 453 - 455
  • [32] Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients A meta-analysis
    Fan, Guiyong
    Zhao, Qun
    Lu, Pei
    Chen, Hao
    Tan, Wei
    Guo, Weixiao
    Liu, Chaoqun
    Liu, Jinlian
    [J]. MEDICINE, 2020, 99 (15) : E18964
  • [33] EFFECTS OF ROMOSOZUMAB ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: A META-ANALYTIC SYNTHESIS OF RANDOMIZED CONTROLLED TRIALS
    Azharuddin, M.
    Sharma, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S354 - S354
  • [34] Fracture Risk Reduction with Romosozumab: Results of a Phase 3 Study in Postmenopausal Women with Osteoporosis
    Cosman, F.
    Crittenden, D. B.
    Adachi, J. D.
    Binkley, N.
    Czerwinski, E.
    Ferrari, S.
    Hofbauer, L. C.
    Lau, E.
    Lewiecki, E. M.
    Miyauchi, A.
    Zerbini, C. A. F.
    Milmont, C. E.
    Chen, L.
    Maddox, J.
    Meisner, P. D.
    Libanati, C.
    Grauer, A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [35] Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture
    Clarke, Bart
    Kostenuik, Paul
    Wang, Yamei
    Tough-DeSapri, Kristi
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1448 - 1448
  • [36] Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
    Genant, Harry K.
    Engelke, Klaus
    Bolognese, Michael A.
    Mautalen, Carlos
    Brown, Jacques P.
    Recknor, Chris
    Goemaere, Stefan
    Fuerst, Thomas
    Yang, Yu-Ching
    Grauer, Andreas
    Libanati, Cesar
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (01) : 181 - 187
  • [37] Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
    Cosman, Felicia
    Lane, Nancy E.
    Bolognese, Michael A.
    Zanchetta, Jose R.
    Garcia-Hernandez, Pedro A.
    Sees, Karen
    Matriano, James A.
    Gaumer, Kim
    Daddona, Peter E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 151 - 158
  • [38] BONE MINERAL DENSITY AND BONE TURNOVER MARKERS AFTER ONE-YEAR TERIPARATIDE TREATMENT IN KOREAN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Oh, H.
    Choi, W.
    Choi, H.
    Kim, J.
    Lim, S.
    Joo, I.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 183 - 184
  • [39] Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
    Tanaka, Shiro
    Kuroda, Tatsuhiko
    Sugimoto, Toshitsugu
    Nakamura, Toshitaka
    Shiraki, Masataka
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 931 - 936
  • [40] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    Watts, N. B.
    Hattersley, G.
    Fitzpatrick, L. A.
    Wang, Y.
    Williams, G. C.
    Miller, P. D.
    Cosman, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1187 - 1194
12345